Inadequate antibody response to rabies vaccine in immuno-compromised patient

Emerging Infectious Diseases

Volumn 18, Issue 9, 2012, Pages 1493-1495

  Kopel, Eran ^a,b   Oren, Gal ^a   Sidi, Yechezkel ^a,c   David, Dan ^d  

^a SHEBA MEDICAL CENTER   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d KIMRON VETERINARY INSTITUTE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; RABIES IMMUNOGLOBULIN; RABIES VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGED; ANTIBODY RESPONSE; ARTICLE; B CELL LYMPHOMA; BITE; CASE REPORT; EMPORIATRICS; FEMALE; HAPLORHINI; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; LYMPH NODE BIOPSY; LYMPHOCYTOPENIA; POST EXPOSURE PROPHYLAXIS; RABIES; SEPSIS; WEAKNESS;

AGED; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BITES AND STINGS; FEMALE; HAPLORHINI; HUMANS; IMMUNOCOMPROMISED HOST; POST-EXPOSURE PROPHYLAXIS; RABIES; RABIES VACCINES; RABIES VIRUS;

EID: 84865329107     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1809.111833     Document Type: Article

References (14)

1. Rupprecht CE, Gibbons RV. Clinical practice. Prophylaxis against rabies. N Engl J Med. 2004;351:2626-2635. http://dx.doi.org/10.1056/NEJMcp042140
2. Hankins DG, Rosekrans JA. Overview, prevention, and treatment of rabies. Mayo Clin Proc. 2004;79:671-676. http://dx.doi. org/10.4065/79.5.671
3. Warrell MJ, Warrell DA. Rabies and other lyssavirus diseases. Lancet. 2004;363:959-969. http://dx.doi.org/10.1016/S0140-6736(04)15792-9
4. World Health Organization. Rabies vaccines: WHO position paper. Wkly Epidemiol Rec. 2010;85:309-320 [cited 2011 Nov 13]. http:// www.who.int/wer/2010/wer8532.pdf
5. Israel Ministry of Health, Public Health Services. Guidelines for rabies prevention [in Hebrew]. Circular no. 3/2010, May 26, 2010.
6. Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, Kerr HD, et al. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep. 2010;59:1-9.
7. Smith JS, Yager PA, Baer GM. A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ. 1973;48:535-541.
8. Pancharoen C, Thisyakorn U, Tantawichien T, Jaijaroensup W, Khawplod P, Wilde H. Failure of pre- and postexposure rabies vaccinations in a child infected with HIV. Scand J Infect Dis. 2001;33:390-391. http://dx.doi.org/10.1080/003655401750174183
9. Jaijaroensup W, Tantawichien T, Khawplod P, Tepsumethanon S, Wilde H. Postexposure rabies vaccination in patients infected with human immunodefi ciency virus. Clin Infect Dis. 1999;28:913-914. http://dx.doi.org/10.1086/517241
10. Tantawichien T, Jaijaroensup W, Khawplod P, Sitprija V. Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodefi ciency virus with low CD4+ T lymphocyte counts. Clin Infect Dis. 2001;33:e122-e124. http://dx.doi.org/10.1086/324087
11. Hay E, Derazon H, Bukish N, Scharf S, Rishpon S. Postexposure rabies prophylaxis in a patient with lymphoma. JAMA. 2001;285:166-167. http://dx.doi.org/10.1001/jama.285.2.166
12. Rodríguez-Romo R, Morales-Buenrostro LE, Lecuona L, Escalante-Santillán N, Velasco-Villa A, Kuzmin I, et al. Immune response after rabies vaccine in a kidney transplant recipient. Transpl Infect Dis. 2011;13:492-495. http://dx.doi.org/10.1111/j.13993062.2011.00665.x.
13. Schneider E, Whitmore S, Glynn KM, Dominguez K, Mitsch A, McKenna MT; for the Centers for Disease Control and Prevention. Revised surveillance case defi nitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years- United States, 2008. MMWR Recomm Rep. 2008;57:1-12.
14. World Health Organization. WHO expert consultation on rabies. World Health Organ Tech Rep Ser. 2005;931:1-88.